- 恒指
- 26,361
- +201
- 大市成交 2,415億
- 正海生物
- 18.750-0.900 (-4.580%)
盈利能力分析
- 1.645
- 9.269
- 14.660
- 21.063
- 22.472
- 1.484
- 8.389
- 13.239
- 18.715
- 19.358
- 1.613
- 9.064
- 14.179
- 20.226
- 21.433
邊際利潤分析
- 82.648
- 85.877
- 87.643
- 89.901
- 88.723
- 21.210
- 24.504
- 41.987
- 52.839
- 48.952
- 21.172
- 24.105
- 41.809
- 52.655
- 48.753
- 18.203
- 22.632
- 37.068
- 46.164
- 42.804
收益指標分析
- 81.057
- 83.286
- 83.694
- 87.543
- 93.008
- 17.761
- 15.369
- 11.847
- 11.569
- 3.393
- 0.087
- -1.250
- -0.085
- -0.080
- 0.017
償債能力分析
- 8.420
- 8.604
- 8.822
- 8.562
- 6.723
- 8.065
- 8.257
- 8.386
- 8.154
- 6.337
- 9.838
- 9.663
- 9.318
- 10.036
- 12.341
- 1.066
- 0.603
- 1.557
- 2.205
- 2.366
- 9,179.319
- 16,292.830
- 6,249.212
- 4,362.996
- 4,050.358
- 916.499
- 934.921
- 973.162
- 896.437
- 710.287
- -374.719
- -250.962
- -294.261
- -369.890
- -235.612
營運能力分析
- 64.500
- 52.235
- 49.363
- 42.093
- 37.683
- 195.502
- 226.576
- 288.338
- 333.560
- 275.121
中東戰火
大國博弈
More